The Lancet. Gastroenterology & Hepatology
-
Publication Venue For
-
Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial..
7:603-616.
2022
-
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial..
7:307-317.
2022
-
Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis..
6:638-648.
2021
-
Irritable bowel syndrome: a spotlight on future research needs..
6:419-422.
2021
-
Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials..
6:401-410.
2021
-
Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis..
6:359-370.
2021
-
Efficacy of surgical or endoscopic treatment of idiopathic achalasia: a systematic review and network meta-analysis..
6:30-38.
2021
-
Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis..
5:1053-1062.
2020
-
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis..
5:908-917.
2020
-
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..
5:582-597.
2020
-
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..
5:245-266.
2020
-
Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis..
5:117-131.
2020
-
The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017..
5:42-54.
2020
-
Biofeedback or loperamide for faecal incontinence in women - Author's reply..
4:904-905.
2019
-
The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..
4:913-933.
2019
-
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..
4:934-947.
2019
-
Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis..
4:831-844.
2019
-
Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study..
4:794-804.
2019
-
Controlling faecal incontinence in women by performing anal exercises with biofeedback or loperamide: a randomised clinical trial..
4:698-710.
2019
-
The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment..
4:632-642.
2019
-
Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial..
3:837-844.
2018
-
Stool as a treatment for IBS: more questions than answers?.
3:2-3.
2018
-
Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study..
2:418-426.
2017
-
Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis..
2:189-199.
2017
-
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium..
2:103-111.
2017
-
Pathophysiology of irritable bowel syndrome..
1:133-146.
2016